Back to 
Verition Fund Management LLC
Verition Fund Management LLC
CUE
Showing 0 of 2 quarters
Position history for Verition Fund Management LLC's holdings in CUE BIOPHARMA INC
No. Verition Fund Management exited its CUE (Cue Biopharma) position in Q3 2023. Its Q2 2023 13F listed 21,001 shares worth $76,654. Verition Fund Management first reported CUE in Q2 2023 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.